Counterfeit Drug Prevention in Pharma Supply Chain using Blockchain Technology

Fake drugs are a growing serious issue related to the healthcare industry which causes extraordinary dangers to the society and the environment. Tracing the drugs at every step of the pharma supply chain is a difficult task. The goal of the research is to create a blockchain-based model that can forestall drug forging in drug store networks. The scope of the research lies where irregularities in the pharmaceutical supply chain affect public health and economy. The advanced elements of Blockchain makes it fit for complete recognizability of medications from producer to end patients, and the capacity to prevent fake prescriptions or medications. Drugs change proprietorship from producers to distributors and afterward retailers before it arrives at the client. Through the proposed model, the producer would have the option to transfer the subtleties relating to a medication, after which it will be sent for endorsement to the Government. From there on, distributors and retailers, in view of their prerequisites, can demand the endorsed drugs. Later on, in the event that a patient needs some drug, the person should demand it on the blockchain network. The solicitation will be shipped off the closest retailer/drug store and from that point, the patient can gather their medicine. Hyperledger fabric is utilized because they are permissioned and have an open source blockchain framework, meaning all the organization and pears are well known and confirmed. Our execution of the proposed blockchain based model features that the model can effectively forestall any medication being fake. This will be advantageous for the clients getting impacted with fake medications.